Cargando…
Enfermedad neumocócica en el adulto: niveles de riesgo y recomendaciones de vacunación
There are currently two anti-pneumococcal vaccines available for use in adults: the classical 23-valent polysaccharide pneumococcal vaccine (PPV23) and the new 13-valent pneumococcal conjugate vaccine (PCV13). The main advantage of the PCV13 is the potentially better immunogenicity, with its major d...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875917/ https://www.ncbi.nlm.nih.gov/pubmed/27765456 http://dx.doi.org/10.1016/j.aprim.2016.06.007 |